Dergiler / Experimed / 2023 / Cilt: 13 Sayı: 1

Association of EGFR Gene Polymorphism with Glioma Susceptibility in Turkish Population

Sayfa
54–58
Yayın Tarihi
2023-05-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: As a result of the preliminary findings, having the mutant T allele may increase risk by 3.36 times, whereas having the ancestral homozygote CC genotype lowers the risk for glioma in Turkish population.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Gliomas are devastating adult brain tumors of unknown etiology, occupying 8 out of 10 primary brain tumors.
📊
Temel Bulgular & Veri:Epidermal growth factor receptor (EGFR) as a tyrosine kinase family member is encoded by the EGFR gene located in chromosome 7p12-13.
💡
Sonuç & Katkı:Conclusion: As a result of the preliminary findings, having the mutant T allele may increase risk by 3.36 times, whereas having the ancestral homozygote CC genotype lowers the risk for glioma in Turkish population.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Glioma · EGFR Gene · Variation

Abstract

Objective: Gliomas are devastating adult brain tumors of unknown etiology, occupying 8 out of 10 primary brain tumors. Epidermal growth factor receptor (EGFR) as a tyrosine kinase family member is encoded by the EGFR gene located in chromosome 7p12-13. Various studies have identified numerous SNPs, including those in the EGFR gene, as linked to gliomas. The objective of the investigation was to determine whether the genotype and allele frequencies of the EGFR may have a role in glioma susceptibility. Materials and Methods: To examine the association of EGFR SNP rs1468727 with glioma susceptibility in a case-control study from Türkiye (34 cases, 36 controls), genotyping and statistical analyses were performed by using real-time-polymerase chain reaction (RT-PCR) and SPSS version 25.0, respectively. Results: A significant relationship was found between the study groups EGFR SNP rs1468727 genotypes (p = 0.028). The CC genotype frequency was significantly greater in the control group compared to the glioma group (p=0.005). When compared with the control group, the frequency of mutant type T allele carriers was significantly higher in glioma patients (p=0.012). Conclusion: As a result of the preliminary findings, having the mutant T allele may increase risk by 3.36 times, whereas having the ancestral homozygote CC genotype lowers the risk for glioma in Turkish population.

🔖

Bu Makaleye Atıf Yap

OZCAN, G., AKDENİZ, F. T., GÜLEÇ, S., BARUT, Z., BİLLUR, D., İSBİR, T., YALTIRIK, C. K. (2023). Association of EGFR Gene Polymorphism with Glioma Susceptibility in Turkish Population. Experimed, Cilt: 13 Sayı: 1, 54–58. https://ajindex.com/articles/936355

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Ostrom, QT, Francis SS, Barnholtz-Sloan JS. Epidemiology of brain and other CNS tumors. Curr Neurol Neurosci Rep 2021
  2. 21(12): 68. [CrossRef] google scholar 2. Mayer O, Bugis J, Kozlova D, Leemann A, Mansur S, Peerutin I, et al. Cytoskeletal protein palladin in adult gliomas predicts disease incidence, progression, and prognosis. Cancers 2022
  3. 14(20): 5130. [CrossRef] google scholar 3. Finch A, Solomou G, Wykes V, Pohl U, Bardella C, Watts C. Advances in research of adult gliomas. Int J Mol Sci 2021
  4. 22(2): 924. [CrossRef] google scholar 4. Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR. Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol 2019
  5. 15(7): 405-17. [CrossRef] google scholar 5. Kinnersley B, Houlston RS, Bondy ML. Genome-wide association studies in glioma. Cancer Epidemiol Biomarkers Prev 2018
  6. 27(4): 418-28. [CrossRef] google scholar 6. Li B, Zhao W, Li J, Yan M, Xie Z, Zhu Y, et al. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients. Oncotarget 2016
  7. 7(39): 63054-64. [CrossRef] google scholar 7. Arienti C, Pignatta S and Tesei A. Epidermal growth factor receptor family and its role in gastric cancer. Front Oncol 2019
  8. [CrossRef] google scholar 8. Hajdu T, Varadi T, Rebenku I, Kovacs T, Szöllösi J, Nagy P. Comprehensive model for epidermal growth factor receptor ligand binding involving conformational states of the extracellular and the kinase domains. Front Cell Dev Biol 2020
  9. [CrossRef] google scholar 9. Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010
  10. 12(9): 675-84. [CrossRef] google scholar 10. Taylor TE, Furnari FB, Cavenee WK. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets 2012
  11. 12(3): 197-209. [CrossRef] google scholar 11. Lee A, Arasaratnam M, Chan DLH, Khasraw M, Howell VM, Wheeler H. Anti-epidermal growth factor receptor therapy for glioblastoma in adults. Cochrane Database Syst Rev 2020
  12. 5(5): CD013238. [CrossRef] google scholar 12. Oktay Y. Ulgen E, Can O, Akyerli C, Yuksel S, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep 2016
  13. 27569. [CrossRef] google scholar 13. Ozden M, Katar S, Hanimoglu H, Ulu MO, Isler C, Baran O, et al. Polymorphisms in the matrix metalloproteinase-9 promoters and s